94 related articles for article (PubMed ID: 20334584)
1. The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome.
Lenarcik A; Bidzińska-Speichert B; Tworowska-Bardzińska U
Gynecol Endocrinol; 2010 Sep; 26(9):673-83. PubMed ID: 20334584
[TBL] [Abstract][Full Text] [Related]
2. The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.
San Millán JL; Alvarez-Blasco F; Luque-Ramírez M; Botella-Carretero JI; Escobar-Morreale HF
Hum Reprod; 2006 Dec; 21(12):3157-61. PubMed ID: 16880229
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
4. PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenaemia.
Paltoglou G; Tavernarakis G; Christopoulos P; Vlassi M; Gazouli M; Deligeoroglou E; Creatsas G; Mastorakos G
Clin Endocrinol (Oxf); 2013 Aug; 79(2):259-66. PubMed ID: 23278234
[TBL] [Abstract][Full Text] [Related]
5. [Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome].
Knebel B; Janssen OE; Hahn S; Nitzgen U; Jacob S; Haas J; Mack S; Müller-Wieland D; Kotzka J
Dtsch Med Wochenschr; 2009 May; 134(20):1040-6. PubMed ID: 19421925
[TBL] [Abstract][Full Text] [Related]
6. No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia.
Marioli DJ; Koika V; Adonakis GL; Saltamavros AD; Karela A; Armeni AK; Tsapanos VS; Decavalas GO; Georgopoulos NA
Arch Gynecol Obstet; 2010 Jun; 281(6):1045-9. PubMed ID: 20012307
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase levels in women with polycystic ovary syndrome.
Fenkci IV; Serteser M; Fenkci S; Kose S
J Reprod Med; 2007 Oct; 52(10):879-83. PubMed ID: 17977159
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].
Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
11. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
[TBL] [Abstract][Full Text] [Related]
12. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
[TBL] [Abstract][Full Text] [Related]
13. Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?
Christopoulos P; Mastorakos G; Gazouli M; Deligeoroglou E; Katsikis I; Diamanti-Kandarakis E; Panidis D; Creatsas G
Gynecol Endocrinol; 2010 Sep; 26(9):698-703. PubMed ID: 20210696
[TBL] [Abstract][Full Text] [Related]
14. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women.
Márquez JL; Pacheco A; Valdés P; Salazar LA
Clin Chim Acta; 2008 Dec; 398(1-2):5-9. PubMed ID: 18722363
[TBL] [Abstract][Full Text] [Related]
15. The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome.
Chen MJ; Chen HF; Chen SU; Ho HN; Yang YS; Yang WS
Fertil Steril; 2009 Dec; 92(6):2041-4. PubMed ID: 19591997
[TBL] [Abstract][Full Text] [Related]
16. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
17. Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in southwest Chinese women.
Wang Y; Liu H; Fan P; Bai H; Zhang J; Zhang F
Eur J Endocrinol; 2012 May; 166(5):877-85. PubMed ID: 22301914
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
[TBL] [Abstract][Full Text] [Related]
19. Genomic variants in polycystic ovary syndrome.
Luque-Ramírez M; San Millán JL; Escobar-Morreale HF
Clin Chim Acta; 2006 Apr; 366(1-2):14-26. PubMed ID: 16337616
[TBL] [Abstract][Full Text] [Related]
20. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
